Understanding inflammatory markers, metabolic testing, and the difference between detecting a problem and identifying its cause.
By Lisa Martin, Ballymoon Farm.
When a horse is not quite himself, there is something reassuring about the idea of a blood test.
A small sample, a laboratory report, and a collection of numbers that may explain what our eyes cannot.
Perhaps the pony has become quieter.
Perhaps an older horse is losing muscle.
Perhaps an easy keeper remains overweight despite careful feeding.
Or perhaps the owner simply wants to know whether hidden inflammation is affecting an otherwise healthy animal.
Bloodwork can be enormously valuable.
But its greatest usefulness comes from understanding what each test actually measures.
A blood test does not provide a complete picture of health.
And an abnormal result is not necessarily a diagnosis.
Serum amyloid A, commonly abbreviated SAA, is one of the most useful inflammatory markers in equine medicine.
It is an acute-phase protein produced predominantly by the liver in response to inflammatory signaling.
In healthy horses, circulating SAA concentrations are generally very low.
When significant inflammation develops, concentrations can rise rapidly and dramatically.
This makes SAA useful when veterinarians are investigating suspected infection, inflammatory disease, or complications following surgery.
It may also help monitor whether an inflammatory process is improving or worsening.
But SAA has an important limitation.
It does not identify the cause.
An elevated result may accompany respiratory infection, gastrointestinal disease, reproductive tract inflammation, septic arthritis, tissue injury, or other inflammatory conditions.
It is a signal that requires interpretation.
SAA is sometimes discussed as though it were a universal measure of hidden inflammation.
That is misleading.
Although SAA is highly useful for many acute inflammatory conditions, it has not been validated as a stand-alone test for the subtle inflammatory signaling associated with obesity, aging, or metabolic dysfunction.
A horse with insulin dysregulation may have a normal SAA concentration.
A horse with a localized chronic disorder may also have a normal result.
Conversely, a horse with elevated SAA may have an inflammatory problem unrelated to metabolism.
This is why an SAA result should be interpreted alongside the clinical examination, history, and other diagnostic findings.
Fibrinogen is another protein that can increase during inflammatory responses.
Compared with SAA, fibrinogen generally responds more slowly and often changes less dramatically.
This can make the two markers useful in different circumstances.
SAA may provide a sensitive indication of recent inflammatory activity.
Fibrinogen may contribute additional information when evaluating an ongoing inflammatory process.
Neither is specific to a particular disease.
Their value comes from the clinical context and, when appropriate, changes measured over time.
A complete blood count, or CBC, measures several components of circulating blood.
These include red blood cells, white blood cells, and platelets.
Changes in white blood cell numbers or patterns may support concern about infection, inflammation, stress, or other conditions.
But white blood cell counts are influenced by numerous factors.
A normal CBC does not rule out inflammatory disease.
An abnormal CBC does not automatically prove infection.
The veterinarian must interpret the findings in relation to the horse’s symptoms, examination, and other laboratory results.
A serum chemistry panel provides information about several aspects of internal physiology.
It may include measurements related to liver function, kidney function, protein balance, electrolytes, and muscle enzymes.
These tests can help identify organ dysfunction or metabolic disturbances that may contribute to a horse’s clinical problems.
For example, an older pony with muscle loss may need evaluation for nutritional deficiencies, endocrine disease, or chronic illness.
But a routine chemistry panel cannot reliably diagnose every cause of muscle loss or chronic inflammation.
It is one part of a broader assessment.
For the easy-keeping pony, insulin testing may be more clinically relevant than inflammatory markers.
Insulin dysregulation is central to equine metabolic syndrome and strongly associated with endocrinopathic laminitis risk.
Veterinarians may evaluate basal insulin concentrations or use an appropriate dynamic test, depending on the horse and circumstances.
Test selection, feeding status, recent exercise, illness, and laboratory methods can influence interpretation.
A normal basal insulin result does not always exclude insulin dysregulation.
This is one reason dynamic testing may be appropriate when clinical suspicion remains high.
The important distinction is that insulin tests assess endocrine regulation.
They are not tests for systemic inflammation.
Pituitary pars intermedia dysfunction, or PPID, becomes increasingly relevant as horses age.
It may be associated with abnormal coat shedding, muscle loss, changes in fat distribution, recurrent infections, and increased laminitis risk when insulin dysregulation is also present.
Plasma ACTH measurement is commonly used in diagnosis.
Interpretation must account for season, laboratory methods, clinical findings, and other factors.
In selected cases, additional testing may be recommended.
A pony with PPID may also have insulin dysregulation, but the two conditions should be evaluated separately.
For Connemara owners, the most useful testing strategy is usually based on individual risk rather than breed identity alone.
A young, fit pony with no clinical concerns may not require an extensive panel of inflammatory tests.
An overweight Connemara with a pronounced crest and a history of laminitis may benefit from focused endocrine evaluation.
An older pony with muscle loss and abnormal coat shedding may warrant PPID testing.
A pony with unexplained fever or declining appetite may require a very different diagnostic approach.
The question is not simply which blood tests are available.
It is which tests can answer the clinical question in front of us.
A single laboratory result represents one moment in time.
Serial measurements can sometimes be more informative.
For example, a veterinarian monitoring a diagnosed inflammatory condition may use repeated SAA measurements to assess response to treatment.
An insulin-dysregulated pony may undergo follow-up endocrine testing after changes in diet, exercise, or medication.
But repeated testing should have a purpose.
A rising or falling number is meaningful only when we understand what is being measured and what other factors may influence it.
There is a temptation to treat every laboratory abnormality as something that must be corrected.
But reference intervals describe expected values in a particular population and testing context.
They do not guarantee health.
Nor does a result outside the reference interval automatically indicate serious disease.
A mildly abnormal value may reflect biological variation, laboratory variation, recent activity, or a genuine clinical problem.
The veterinarian’s responsibility is to determine which explanation is most likely.
The owner’s responsibility is not to purchase a supplement for every number that appears outside the laboratory range.
Bloodwork cannot replace observation.
It cannot replace a thorough physical examination.
It cannot substitute for dental assessment, lameness evaluation, appropriate imaging, or careful nutritional analysis when those are indicated.
And it cannot identify every form of disease.
The most effective diagnostic process begins with a question, not a laboratory shopping list.
For breeders and owners, understanding bloodwork provides a more useful kind of reassurance than simply receiving a page of normal results.
It helps us recognize the difference between metabolic risk and inflammatory disease.
It helps us understand why one pony needs insulin testing while another needs investigation for infection.
And it reminds us that good veterinary medicine is not the pursuit of perfect numbers.
It is the pursuit of meaningful answers.
The invisible becomes useful only when we know what we are looking for.
This article belongs to The Inflammation Series in the Connemara Breeder’s Library:
Jacobsen S. (2023). Use of serum amyloid A in equine medicine and surgery. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13195
Nolen-Walston R, et al. (2020). Equine inflammatory markers in the twenty-first century: A focus on serum amyloid A. Veterinary Clinics of North America: Equine Practice. https://doi.org/10.1016/j.cveq.2019.12.005
Equine Endocrinology Group. Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (2022).
Equine Endocrinology Group. Recommendations for the Diagnosis and Management of PPID (2023).
Educational information only. Laboratory tests must be interpreted by a veterinarian in the context of the individual horse.
Ballymoon Farm | The Breeder’s Library
For more of our latest photos and inspiration, follow along on instagram at @instapony_.
© Redbud Ranch 2020 | Connemara Sport Horses and Ponies | photos by Lisa Martin |
terms & Condtions |
privacy Policy
Intentionally Bred with People in Mind
Browns Valley, CA
+ Show / Hide Comments
Share to: